Safety and effectiveness of RBD-specific polyclonal equine F(ab′)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study

Diego H. Farizano Salazar, Fernando Achinelli, Mariana Colonna, Lucía Perez, Analía A. Giménez, Maria Alejandra Ojeda, Susana N. Miranda Puente, Lía Sánchez Negrette, Florencia Cañete, Ornela I. Martelotte Ibarra, Santiago Sanguineti, Linus Spatz, Fernando A. Goldbaum, Carolina Massa, Marta Rivas, Mariana Pichel, Yanina Hiriart, Vanesa Zylberman, Sandra Gallego, Brenda Konigheim, Francisco Fernandez, Matías Deprati, Ian Roubicek, Diego H. Giunta, Esteban Nannini, Gustavo Lopardo, Waldo H. Belloso EPIC Study Group
doi: https://doi.org/10.1101/2022.04.07.22273558

Data Availability

All data produced in the present study are available upon reasonable request to the authors

https://ClinicalTrials.gov

Back to top
Posted April 17, 2022.
Download PDF
Data/Code
Email
Safety and effectiveness of RBD-specific polyclonal equine F(ab′)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: a retrospective cohort study
Diego H. Farizano Salazar, Fernando Achinelli, Mariana Colonna, Lucía Perez, Analía A. Giménez, Maria Alejandra Ojeda, Susana N. Miranda Puente, Lía Sánchez Negrette, Florencia Cañete, Ornela I. Martelotte Ibarra, Santiago Sanguineti, Linus Spatz, Fernando A. Goldbaum, Carolina Massa, Marta Rivas, Mariana Pichel, Yanina Hiriart, Vanesa Zylberman, Sandra Gallego, Brenda Konigheim, Francisco Fernandez, Matías Deprati, Ian Roubicek, Diego H. Giunta, Esteban Nannini, Gustavo Lopardo, Waldo H. Belloso
medRxiv 2022.04.07.22273558; doi: https://doi.org/10.1101/2022.04.07.22273558
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area